Steve Yancey
- The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophiliaBy Hector Ortega, Geoffrey Chupp, Philip Bardin, Arnaud Bourdin, Gilles Garcia, Benjamin Hartley, Steve Yancey and Marc HumbertHector Ortega1GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USAGeoffrey Chupp2Dept of Pulmonary and Critical Care, Yale University Medical School, Winchester Chest Clinic, 20 York Street, New Haven, CT, USAPhilip Bardin3Monash University and Medical Centre, Lung and Sleep, Melbourne, AustraliaArnaud Bourdin4Dept of Allergy, Hospital Arnaud de Villeneuve, Montpellier, FranceGilles Garcia5University Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, FranceBenjamin Hartley7GlaxoSmithKline, Research and Development, Stockley Park, Middlesex, UKSteve Yancey1GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USAMarc Humbert5University Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France8Inserm U999, LabEx LERMIT, Le Plessis Robinson, France
- The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophiliaBy Hector Ortega, Geoffrey Chupp, Philip Bardin, Arnaud Bourdin, Gilles Garcia, Benjamin Hartley, Steve Yancey and Marc HumbertArticle | Published in 2014 in European Respiratory JournalHector Ortega1GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USAGeoffrey Chupp2Dept of Pulmonary and Critical Care, Yale University Medical School, Winchester Chest Clinic, 20 York Street, New Haven, CT, USAPhilip Bardin3Monash University and Medical Centre, Lung and Sleep, Melbourne, AustraliaArnaud Bourdin4Dept of Allergy, Hospital Arnaud de Villeneuve, Montpellier, FranceGilles Garcia5University Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, FranceBenjamin Hartley7GlaxoSmithKline, Research and Development, Stockley Park, Middlesex, UKSteve Yancey1GlaxoSmithKline, Respiratory Medicine Development Center, Research Triangle Park, NC, USAMarc Humbert5University Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France6AP-HP, Service de Pneumologie, DHU Thorax Innovation, Hôpital Bicêtre, Le Kremlin-Bicêtre, France8Inserm U999, LabEx LERMIT, Le Plessis Robinson, France
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.